Access to anti-retroviral drugs, female in Iraq
Iraq: Access to anti-retroviral drugs, female was 67.0% in 2024. ▲ Rising
Access to anti-retroviral drugs, female in Iraq, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Iraq recorded 67.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 21.8% on the previous year and up 168.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Iraq peaked at 67.0% in 2024 and was at its lowest, 17.0%, in 2004.
Iraq ranks 88th of 141 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Access to anti-retroviral drugs, female in Iraq, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 19.0% | — |
| 2001 | 18.0% | -5.3% |
| 2002 | 19.0% | +5.6% |
| 2003 | 18.0% | -5.3% |
| 2004 | 17.0% | -5.6% |
| 2005 | 17.0% | +0.0% |
| 2006 | 18.0% | +5.9% |
| 2007 | 20.0% | +11.1% |
| 2008 | 20.0% | +0.0% |
| 2009 | 20.0% | +0.0% |
| 2010 | 20.0% | +0.0% |
| 2011 | 20.0% | +0.0% |
| 2012 | 21.0% | +5.0% |
| 2013 | 23.0% | +9.5% |
| 2014 | 25.0% | +8.7% |
| 2015 | 28.0% | +12.0% |
| 2016 | 30.0% | +7.1% |
| 2017 | 34.0% | +13.3% |
| 2018 | 37.0% | +8.8% |
| 2019 | 41.0% | +10.8% |
| 2020 | 40.0% | -2.4% |
| 2021 | 42.0% | +5.0% |
| 2022 | 51.0% | +21.4% |
| 2023 | 55.0% | +7.8% |
| 2024 | 67.0% | +21.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 18.6% | 17.0% | 20.0% | 10 |
| 2010s | 27.9% | 20.0% | 41.0% | 10 |
| 2020s | 51.0% | 40.0% | 67.0% | 5 |
Countries ranked near Iraq
- 86 Dominican Republic 68.0% compare
- 86 Mauritania 68.0% compare
- 88 Barbados 67.0% compare
- 88 Jordan 67.0% compare
- 91 Algeria 65.0% compare
- 91 Costa Rica 65.0% compare
- 91 Malaysia 65.0% compare
- 91 Montenegro 65.0% compare
More gender data for Iraq
- Child population (UN estimates and projections) 17,091 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.3028 % change on previous year (2030)
- Population 34,846 (2030)
- Working-age population (UN estimates and projections) 34,846 (2030)
- Population (UN estimates and projections), annual growth rate 2.78 % change on previous year (2030)
- Age population, age 00, female, interpolated 566,580 (2025)
- Age population, age 00, male, interpolated 596,188 (2025)
- Age population, age 01, female, interpolated 558,252 (2025)
- Age population, age 01, male, interpolated 587,298 (2025)
- Age population, age 02, female, interpolated 550,204 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Iraq?
- Access to anti-retroviral drugs, female in Iraq was 67.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Iraq?
- The highest recorded value was 67.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Iraq?
- The lowest recorded value was 17.0% in 2004.
- How does Iraq rank for access to anti-retroviral drugs, female?
- Iraq ranks 88th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Iraq?
- Over the last ten years it is up 168.0%. The long-run trend across the full record is rising.
- Where does this Iraq data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.